Haemonetics Corporation (HAE) Q2 2021 Earnings Results

Haemonetics Corp Beats on EPS, Stock Down 6.75%

Haemonetics Corp reported a strong EPS performance, significantly exceeding expectations. However, the stock fell by 6.75% following the earnings report, likely due to the lack of revenue data and guidance. Investors may be concerned about future performance without clearer direction from management.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.94	N/A	+89.90%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to growth. However, they acknowledged ongoing challenges in the market.

We are pleased with our EPS performance this quarter.

Despite challenges, we are focused on our long-term growth strategy.

Haemonetics Corp Beats on EPS, Stock Down 6.75%

Key numbers

Management commentary

Haemonetics Corporation

More earnings this week

Haemonetics Corp Beats on EPS, Stock Down 6.75%

Key numbers

Management commentary